However, the expressions of PI3K, p-AKT/AKT, mTOR, and PPAR-γ were significantly decreased with APE and AFE treatment in comparison with the model group (Figure 7A–D). The gene discussed is MTOR; the disease is apparent mineralocorticoid excess.